Stay updated on Fostamatinib in Warm Autoimmune Hemolytic Anemia Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib in Warm Autoimmune Hemolytic Anemia Clinical Trial page.

Latest updates to the Fostamatinib in Warm Autoimmune Hemolytic Anemia Clinical Trial page
- Check6 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for a Phase 3 fostamatinib extension study, including its eligibility criteria, locations, interventions, and outcomes.SummaryDifference51%

- Check13 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedA banner announces that NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during a transition. It appears above the unavailable study record.SummaryDifference1%

- Check27 days agoChange DetectedThe ClinicalTrials.gov footer now shows revision v3.7.2 instead of v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check34 days agoChange DetectedThe footer site revision changes from v3.7.0 to v3.7.1 while the 403 error page remains otherwise unchanged.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the usual study record content and navigation. This indicates the study information is temporarily inaccessible to users.SummaryDifference16%

Stay in the know with updates to Fostamatinib in Warm Autoimmune Hemolytic Anemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib in Warm Autoimmune Hemolytic Anemia Clinical Trial page.